p-hydroxyphenylacetic acid-N, N-dimethylcarbamoylmethyl ester
camostat mesylate
Conditions | Yield |
---|---|
With sodium hydrogencarbonate In pyridine; methanol; diethyl ether |
camostat mesylate
A
4-guanidinobenzoic acid
B
4-(4-guanidinobenzoyloxy)phenylacetic acid
Conditions | Yield |
---|---|
With porcine esterase; sodium phosphate buffer at 37℃; Kinetics; pH 7.0; |
camostat mesylate
A
2-hydroxy-N,N-dimethylacetamide
B
4-hydroxyphenylacetate
C
4-guanidinobenzoic acid
Conditions | Yield |
---|---|
With Tris-HCl buffer; human liver carboxylesterase pI 4.5 at 37℃; pH=7.4; Enzyme kinetics; Hydrolysis; |
camostat mesylate
A
2-hydroxy-N,N-dimethylacetamide
B
4-(4-guanidinobenzoyloxy)phenylacetic acid
Conditions | Yield |
---|---|
With Tris-HCl buffer; human liver carboxylesterase pI 5.3 at 37℃; pH=7.4; Enzyme kinetics; Hydrolysis; |
The Camostat mesilate, with its CAS registry number 59721-29-8, has the IUPAC name of [4-[2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl]phenyl] 4-(diaminomethylideneamino)benzoate; methanesulfonic acid. For being a kind of crystalline solid, its product categories are including All Inhibitors; Inhibitors; Intermediates & Fine Chemicals; Pharmaceuticals. As to its usage, it is used as the protease inhibitor.
The physical properties of this chemical are as below: (1)ACD/LogP: 1.29; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -0.7; (4)ACD/LogD (pH 7.4): -0.23; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 1.23; (8)ACD/KOC (pH 7.4): 3.57; (9)#H bond acceptors: 9; (10)#H bond donors: 4; (11)#Freely Rotating Bonds: 9; (12)Polar Surface Area: 82.4; (13)Flash Point: 337.6 °C; (14)Enthalpy of Vaporization: 93.79 kJ/mol; (15)Boiling Point: 634.6 °C at 760 mmHg; (16)Vapour Pressure: 5.22E-16 mmHg at 25°C; (17)Exact Mass: 494.147135; (18)MonoIsotopic Mass: 494.147135; (19)Topological Polar Surface Area: 200; (20)Heavy Atom Count: 34; (21)Complexity: 695.
In addition, you could convert the following datas into the molecular structure:
(1)Canonical SMILES: CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N.CS(=O)(=O)O
(2)InChI: InChI=1S/C20H22N4O5.CH4O3S/c1-24(2)17(25)12-28-18(26)11-13-3-9-16(10-4-13)29-19(27)14-5-7-15(8-6-14)23-20(21)22;1-5(2,3)4/h3-10H,11-12H2,1-2H3,(H4,21,22,23);1H3,(H,2,3,4)
(3)InChIKey: FSEKIHNIDBATFG-UHFFFAOYSA-N
Below are the toxicity information of this chemical:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intravenous | 200mg/kg (200mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 16, Pg. 590, 1985. | |
mouse | LD50 | oral | 3gm/kg (3000mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 27, Pg. 719, 1985. | |
mouse | LD50 | subcutaneous | 1400mg/kg (1400mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 16, Pg. 590, 1985. | |
rat | LD50 | intravenous | 152mg/kg (152mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 16, Pg. 590, 1985. | |
rat | LD50 | oral | 3gm/kg (3000mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 27, Pg. 719, 1985. | |
rat | LD50 | subcutaneous | 1320mg/kg (1320mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 16, Pg. 590, 1985. |
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View